The Affiliated Cancer Hospital of Guizhou Medical University
Guizhou Province, Guizhou Province

Disclosures:

Presentations

Sep 30

1070 - Induction-Concurrent Chemoradiotherapy with or without Camrelizumab for Postoperative Residual High-Grade Gliomas: An Open, Randomized, Phase II Clinical Study
04:45pm - 04:55pm PT